Bashir Timol, Chief Business Officer of Nemaura Medical Inc (NASDAQ: NMRD), a medical technology company developing sugarBEAT® as a non-invasive, affordable, and flexible Continuous Glucose Monitor (CGM) for use by people with diabetes and pre-diabetics, will hold a group call Thursday, May 16, 2019 at 11 am Eastern/8 am Pacific. Duration: 20 minutes.